Literature DB >> 33379146

Low-Dose Pre-Operative Botulinum Toxin A Effectively Facilitates Complex Ventral Hernia Repair: A Case Report and Review of the Literature.

Ali P Mourad1, Marie Shella De Robles1, Robert D Winn1.   

Abstract

Background: Complex ventral hernias following laparotomy present a unique challenge in that repair is hindered by the lateral tension of the abdominal wall. A novel approach to overcome this is the "chemical component separation" technique. Here, botulinum toxin A (BTA) is instilled into the muscles of the abdominal wall. This induces flaccid paralysis and effectively reduces tension in the wall, allowing the muscles to be successfully joined in the midline during surgery. We describe a method where a large incisional hernia was repaired using this technique and review the variations in methodology. Case report: A woman in her mid-40s developed a ventral hernia in the setting of a previous laparotomy for a small bowel perforation. Computed tomography (CT) of the abdomen demonstrated an 85 (Width) × 95 mm (Length) ventral hernia containing loops of the bowel. Pre-operative botulinum toxin A administration was arranged at the local interventional radiology department. A total of 100 units of BTA were instilled at four sites into the muscular layers of the abdominal wall under CT-fluoroscopic guidance. She underwent an open incisional hernia repair 4 weeks later, where the contents were reduced and the abdominal wall layers were successfully joined in the midline. There was no clinical evidence of hernia recurrence at 3-months follow-up.
Conclusion: Low-dose BTA effectively facilitates the surgical management of large ventral incisional hernias. There is, however, significant variation in the dosage, concentration and anatomical landmarks in which BTA is administered as described in the literature. Further studies are needed to assess and optimise these variables.

Entities:  

Keywords:  botulinum toxins; clostridium botulinum; herniorrhaphy; incisional hernia

Mesh:

Substances:

Year:  2020        PMID: 33379146      PMCID: PMC7824390          DOI: 10.3390/medicina57010014

Source DB:  PubMed          Journal:  Medicina (Kaunas)        ISSN: 1010-660X            Impact factor:   2.430


  22 in total

1.  Effect of volume and concentration on the diffusion of botulinum exotoxin A.

Authors:  T S Jeffrey Hsu; Jeffrey S Dover; Kenneth A Arndt
Journal:  Arch Dermatol       Date:  2004-11

2.  "Components separation" method for closure of abdominal-wall defects: an anatomic and clinical study.

Authors:  O M Ramirez; E Ruas; A L Dellon
Journal:  Plast Reconstr Surg       Date:  1990-09       Impact factor: 4.730

3.  Effect of botulinum toxin type A in lateral abdominal wall muscles thickness and length of patients with midline incisional hernia secondary to open abdomen management.

Authors:  T R Ibarra-Hurtado; C M Nuño-Guzmán; A G Miranda-Díaz; R Troyo-Sanromán; R Navarro-Ibarra; L Bravo-Cuéllar
Journal:  Hernia       Date:  2014-07-18       Impact factor: 4.739

4.  Computed tomographic measurements predict component separation in ventral hernia repair.

Authors:  Laurel J Blair; Samuel W Ross; Ciara R Huntington; John D Watkins; Tanushree Prasad; Amy E Lincourt; Vedra A Augenstein; B Todd Heniford
Journal:  J Surg Res       Date:  2015-06-18       Impact factor: 2.192

5.  Ultrasound-guided therapeutic procedures in the musculoskeletal system.

Authors:  Jose Luis del Cura
Journal:  Curr Probl Diagn Radiol       Date:  2008 Sep-Oct

6.  "Components separation technique" for the repair of large abdominal wall hernias.

Authors:  Tammo S de Vries Reilingh; Harry van Goor; Camiel Rosman; Marc H A Bemelmans; Dick de Jong; Ernst Jan van Nieuwenhoven; Marina I A van Engeland; Robert P Bleichrodt
Journal:  J Am Coll Surg       Date:  2003-01       Impact factor: 6.113

7.  Outcomes of chemical component paralysis using botulinum toxin for incisional hernia repairs.

Authors:  Benjamin Zendejas; Mohammad A Khasawneh; Boris Srvantstyan; Donald H Jenkins; Henry J Schiller; Martin D Zielinski
Journal:  World J Surg       Date:  2013-12       Impact factor: 3.352

Review 8.  Dose equivalence of two commercial preparations of botulinum neurotoxin type A: time for a reassessment?

Authors:  Kai Wohlfarth; Thomas Sycha; Danièle Ranoux; Hans Naver; David Caird
Journal:  Curr Med Res Opin       Date:  2009-07       Impact factor: 2.580

9.  Botulinum toxin (Botox) A for reducing the appearance of facial wrinkles: a literature review of clinical use and pharmacological aspect.

Authors:  Bagus Komang Satriyasa
Journal:  Clin Cosmet Investig Dermatol       Date:  2019-04-10

10.  Preoperative Botulinum Toxin and Progressive Pneumoperitoneum in Loss of Domain Hernias-Our First 100 Cases.

Authors:  José Bueno-Lledó; Omar Carreño-Saenz; Antonio Torregrosa-Gallud; Salvador Pous-Serrano
Journal:  Front Surg       Date:  2020-02-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.